In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients
- 30 June 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 703-710
- https://doi.org/10.1016/0277-5379(91)90170-i
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A low-viscosity epoxy resin embedding medium for electron microscopyPublished by Elsevier ,2004
- Modification of tumor cells by a low dose of Newcastle Disease Virus.European Journal of Immunology, 1988
- A rapid and simple procedure for dissociation of tumor tissue from the human colonZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunityClinical & Experimental Metastasis, 1987
- Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effectsInternational Journal of Cancer, 1986
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Newcastle disease virus pathotypesAvian Pathology, 1974
- Virus-augmented tumor transplantation antigens: Evidence for a helper antigen mechanismInternational Journal of Cancer, 1974
- The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors 1.The role of tissue antigen, nonspecific reactions of nuclear material, and bacterial antigen as a cause for this phenomenonCancer, 1969
- Study of Mechanisms of Radiation-Induced Reproductive Death of Mammalian Cells in Culture: Estimation of Stage at Cell Death and Biological Description of Processes Leading to Cell DeathRadiation Research, 1966